According to a Northwestern Medicine study, men who take daily aspirin have double the risk of melanoma. However, the study also determined that women who take daily aspirin do not have an increased risk of melanoma. The study was published April 27 in the Journal of the American Academy of Dermatology.
“Given the widespread use of aspirin and the potential clinical impact of the link to melanoma, patients and health care providers need to be aware of the possibility of increased risk for men,” said senior study author Dr. Beatrice Nardone, research assistant professor of dermatology at Northwestern University Feinberg School of Medicine. “This does not mean men should stop aspirin therapy to lower the risk of heart attack,” she stressed.
According to Marla Paul, “Nardone was surprised at the results because aspirin is reported to reduce risk of gastric, colon, prostate and breast cancer. And some previous studies have reported a reduced risk in aspirin-exposed men and an increased risk in aspirin-exposed women.”
Nardone suggested increasing patient education about sun exposure, avoiding tanning beds and getting skin checks by a dermatologist, particularly for individuals who are already at high risk for skin cancers.
Resource: North Western
#RDK #RichardDavidKannMelanomaFoundation #SunSmartAmerica #SAM #SunSafety #SunSafe #broadspectrumsunscreen #CDC #skincancer #protectyourskin #thegreatoutdoors
